Steinebach O M, Wolterbeek H T
Department of Radiochemistry, Delft University of Technology, The Netherlands.
Toxicology. 1994 Sep 6;92(1-3):75-90. doi: 10.1016/0300-483x(94)90168-6.
Effects of metallothionein (MT) synthesis inhibiting compounds (actinomycin D, cycloheximide), MT synthesis stimulating compounds (dexamethasone, dibu-cAMP) and interfering metals (Cd, Zn) on copper accumulation were investigated in rat hepatoma tissue culture cells. Copper-metallothionein (Cu-MT) and MT-associated copper levels were determined to find a possible correlation between cytosolic copper concentrations and MT as a Cu-detoxifying protein. Further, intracellular non-MT associated copper levels and levels of GSH and SOD were determined. Cell viability was tested under all experimental conditions by measuring LDH-release, K+ uptake and total cell protein. Administration of dexamethasone and dibu-cAMP showed no effect on MT levels (compared with controls), and only a marginal effect on 64Cu and total Cu accumulation. Administration of actinomycin D resulted in increased copper accumulation in the particulate fraction, possibly due to inhibition of copper secretion processes and/or protein synthesis. Presence of zinc had no effect on MT levels nor on total Cu and 64Cu levels, in contrast with cadmium which drastically enhanced copper accumulation and MT levels in the cells. Cu/MT ratios varied from 1.0 +/- 0.3 to 3.3 +/- 1.2, which is far below the assumed maximum molar ratio of 8-12 mol Cu per mol MT. SOD levels appeared to be enhanced up to 2- or 3-fold in the presence of Cd2+, relative to control values. The role of GSH as Cu-intermediate in intracellular Cu distribution plus its role in copper defence mechanism(s) was tested by application of BSO, an inhibitor of GSH synthesis. It was found that BSO had no effect on intracellular MT level; it was found however that MT-bound copper levels were markedly decreased. The results presented support a model for copper metabolism in hepatoma tissue culture (HTC) cells, where Cu(I) is complexed by GSH immediately after entering the cell. GSH is capable of transferring copper to MT where it is stored. Depletion of GSH (by administration of Cd2+, actinomycin D, cycloheximide) almost instantaneously results in enhanced cellular toxicity. When also MT is depleted (by actinomycin D) non-MT associated, 'free' cytosolic Cu2+ is elevated, and HTC cells rapidly loose their resistance to copper toxicity, as also reflected in loss of cell viability (LDH, K+ and total cell protein).
在大鼠肝癌组织培养细胞中,研究了金属硫蛋白(MT)合成抑制化合物(放线菌素D、环己酰亚胺)、MT合成刺激化合物(地塞米松、二丁酰环磷腺苷)及干扰金属(镉、锌)对铜蓄积的影响。测定了铜-金属硫蛋白(Cu-MT)和与MT相关的铜水平,以探寻胞质铜浓度与作为铜解毒蛋白的MT之间可能存在的相关性。此外,还测定了细胞内与MT无关的铜水平以及谷胱甘肽(GSH)和超氧化物歧化酶(SOD)的水平。在所有实验条件下,通过测量乳酸脱氢酶(LDH)释放、钾离子摄取和总细胞蛋白来检测细胞活力。地塞米松和二丁酰环磷腺苷的给药对MT水平无影响(与对照组相比),对64Cu和总铜蓄积仅有轻微影响。放线菌素D的给药导致颗粒部分铜蓄积增加,这可能是由于铜分泌过程和/或蛋白质合成受到抑制。锌的存在对MT水平以及总铜和64Cu水平均无影响,而镉则显著增强了细胞内的铜蓄积和MT水平。Cu/MT比值在1.0±0.3至~3.3±1.2之间变化,远低于假定的每摩尔MT含8 - 12摩尔铜的最大摩尔比。相对于对照值,在Cd2+存在的情况下,SOD水平似乎提高了2至3倍。通过应用GSH合成抑制剂丁硫氨酸亚砜胺(BSO),测试了GSH作为细胞内铜分布的铜中间体的作用及其在铜防御机制中的作用。发现BSO对细胞内MT水平无影响;然而,发现与MT结合的铜水平显著降低。所呈现的结果支持了肝癌组织培养(HTC)细胞中铜代谢的模型,即Cu(I)进入细胞后立即与GSH络合。GSH能够将铜转移至MT并储存其中。GSH的耗竭(通过给予Cd2+、放线菌素D、环己酰亚胺)几乎立即导致细胞毒性增强。当MT也被耗竭(通过放线菌素D)时,与MT无关的“游离”胞质Cu2+升高,HTC细胞迅速丧失对铜毒性的抗性,这也反映在细胞活力(LDH、钾离子和总细胞蛋白)丧失上。